RAINBOW

Q4 2025 Result Analysis

– Q4FY25 & FY25 Results Summary Q4FY25 (YoY): Revenue: ₹3,701.1 million (+8.5%) EBITDA: ₹1,147.3 million (+8.7%) EBITDA Margin: 31.0% (up 6 bps) PAT: ₹565.5 million (+10.7%) PAT Margin: 15.3% (up 31 bps) FY25 (YoY): Revenue: ₹15,158.7 million (+16.9%) EBITDA: ₹4,898.9 million (+14.2%) EBITDA Margin: 32.3% (down 75 bps) PAT: ₹2,442.3 million (+11.9%) PAT Margin: 16.1% (down 72 bps) Management Commentary: Chairman & MD Ramesh Kancharla acknowledged the seasonal softness in Q4 but highlighted the company's consistent growth and strong performance. With over 2,000 beds across a balanced network of hospitals, the company remains focused on improving occupancy, streamlining operations, and delivering quality care. Conclusion: Rainbow Children’s Medicare delivered healthy revenue and profit growth in both Q4 and FY25, despite minor margin compression on a full-year basis. The consistent performance, robust hospital network, and operational focus provide a solid platform for sustained expansion in the pediatric and maternity healthcare space.